With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...

Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...

How you can make sure you get your RSV vaccine this winterThe UK is the first country to offer a RSV vaccine to help save the ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that spreads seasonally. A new drug and several vaccines that prevent the infection have recently come to market. Here's what you ...

RSV vaccines aren't needed every year. Federal regulators recommend a single dose of RSV vaccine, so If you were vaccinated last year, you won't need another dose this year.

The US Food and Drug Administration has approved a vaccine against the respiratory syncytial virus, or RSV, for adults 60 and older. This vaccine, called Arexvy, is made by the drug company GSK.

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information.

A vaccine to protect infants in their first six months of life — the age group at highest risk of being hospitalized with RSV — is expected to gain FDA approval later this year.

The Food and Drug Administration on Wednesday approved Arexvy, the world's first respiratory syncytial virus (RSV) vaccine — a scientific breakthrough 60 years in the making.

A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and ...